Multi-location optometry groups face an appraisal challenge that single practices never encounter: how do you value a portfolio where each location has different revenue profiles, staff capabilities, and operational maturity? The answer lies in standardizing your appraisal methodology before engaging buyers, and that starts with understanding how acquirers actually evaluate multi-site optometry platforms.

Private equity firms completed over 40 eye care transactions through Q1 2025, continuing a trend that has produced 313 deals totaling $17 billion since 2019. These buyers evaluate multi-location groups fundamentally differently than they assess single practices. They apply portfolio-level analysis, centralization premiums, and operational scalability assessments that can swing valuations by millions of dollars. Operations leaders who understand this methodology position their groups for significantly stronger outcomes.

What You’ll Learn

  1. What Makes Multi-Location Optometry Appraisals Different From Single-Practice Valuations?
  2. How Do EBITDA Multiples Work Across a Portfolio of Locations?
  3. Which Operational Metrics Drive Appraisal Value at Scale?
  4. How Does Centralized Patient Access Impact Your Group’s Valuation?
  5. What Due Diligence Challenges Multiply With Each Location?
  6. How Do PE Buyers and Strategic Acquirers Evaluate Multi-Location Groups Differently?
  7. What Framework Should Operations Leaders Use to Prepare for Appraisal?

What Makes Multi-Location Optometry Appraisals Different From Single-Practice Valuations?

The fundamental shift when appraising multi-location optometry groups is moving from practice-level thinking to portfolio-level analysis. Single-practice valuations typically rely on straightforward calculations: a percentage of gross revenue or a multiple of seller discretionary earnings. Multi-location appraisals require a more sophisticated approach that accounts for how locations interact, where operational synergies exist, and what integration risks an acquirer will face.

Portfolio Synergy Analysis Replaces Location-by-Location Valuation

When PE firms evaluate a multi-location optometry group, they assess what the combined entity can achieve that individual locations cannot. A five-location group with centralized scheduling, shared vendor contracts, and unified marketing generates more value than five independent practices with identical revenue. According to Vision Monday’s 2025 industry analysis, PE-backed groups like AEG Vision and MyEyeDr specifically target practices that can integrate into existing platforms because the synergy value exceeds the standalone practice value.

This synergy analysis examines several dimensions. Buyers calculate what they can save by consolidating back-office functions, how much additional revenue centralized recall programs can generate, and what operational improvements standardized protocols will produce. A group that has already captured some of these synergies commands a premium because the acquirer faces less integration risk and faster time-to-value.

Location Interdependency Creates Complexity

Multi-location groups often have locations that share patients, referrals, or specialized services. One location might handle pediatric optometry for the entire region, while another focuses on medical optometry and dry eye treatment. This interdependency means you cannot simply sum individual location values. Removing or underperforming one location affects the entire network.

Appraisers must map these interdependencies to understand true portfolio value. A location that appears marginally profitable might actually drive patient acquisition for higher-margin locations. Conversely, a high-revenue location might depend on referral volume from smaller practices in the network. Understanding these relationships requires operational data that single-practice appraisals never need to consider.

Management Infrastructure Becomes a Valued Asset

Single practices typically include owner-operator compensation in their valuation calculations. Multi-location groups have developed management infrastructure that represents an asset beyond the individual locations. This includes operations directors, regional managers, centralized billing teams, and HR functions.

Buyers evaluate whether this infrastructure is appropriately sized for current operations and capable of supporting growth. A group with management infrastructure that can handle 10 locations but currently operates 5 has built expansion capability that adds value. Conversely, a group that has outgrown its management capacity faces valuation discounts because the acquirer will need to invest in additional infrastructure post-acquisition.

How Do EBITDA Multiples Work Across a Portfolio of Locations?

EBITDA-based valuation has become the standard methodology for multi-location healthcare transactions, replacing the revenue-based approaches that still dominate single-practice sales. Understanding how acquirers apply EBITDA multiples to optometry portfolios helps operations leaders identify where they can improve valuation before engaging buyers.

Understanding the Multiple Range for Optometry Groups

Current market data shows EBITDA multiples for optometry and eye care practices ranging from 4x for single locations with operational challenges to 12x for high-performing multi-location platforms. This range exists because buyers apply different multiples based on risk factors, growth potential, and strategic fit.

The lower end of this range typically applies to groups with concentrated provider dependency, limited operational systems, or geographic markets with high competition. The upper end applies to groups with strong same-store growth, diversified revenue streams, proven management teams, and strategic geographic positioning that fills gaps in the acquirer’s platform.

For multi-location optometry groups with 5-15 locations, EBITDA multiples commonly fall between 6x and 8x, according to ODSONS Finance industry analysis. Groups that demonstrate operational excellence through documented metrics, standardized protocols, and scalable systems can push toward the higher end of this range.

Portfolio-Level EBITDA Normalization

Calculating EBITDA for a multi-location group requires normalization that accounts for shared services, inter-company transactions, and ownership compensation structures. Raw financial statements rarely provide an accurate picture because costs may be allocated inconsistently across locations, and owner benefits may flow through in various forms. IRS business valuation guidance calls for analysis of historical financial statements and selection of appropriate benefit streams, rates, or multiples, with marketability and control considered where relevant (IRS).

The normalization process begins with consolidated financial statements that eliminate inter-company transactions. Buyers then adjust for market-rate compensation for all owners and key managers, one-time expenses that will not recur post-acquisition, and costs that will be eliminated or reduced through integration. This normalized EBITDA figure becomes the basis for applying multiples.

Operations leaders should complete their own normalization exercise before engaging buyers. This identifies potential issues that could reduce valuation and provides time to address them. It also prevents surprises during due diligence when buyers discover adjustments that the seller had not anticipated.

How Location Mix Affects Portfolio Multiples

Not all locations contribute equally to portfolio value. Acquirers often apply blended multiples based on the quality mix within a portfolio. A group with three strong-performing locations and two underperformers will not receive the same multiple as a group where all five locations meet performance benchmarks.

Buyers may segment the portfolio during analysis, applying higher multiples to locations that meet their investment criteria and lower multiples or even negative adjustments to locations that require significant post-acquisition investment. This segmented approach means that improving your weakest locations often generates more valuation impact than further optimizing your strongest performers.

The practical implication for operations leaders is clear: address underperforming locations before entering the market. This might mean investing in operational improvements, replacing underperforming staff, or in some cases, divesting locations that drag down the portfolio average. For guidance on EBITDA optimization strategies for multi-location healthcare groups, operational cleanup should begin 12-18 months before a planned transaction.

Which Operational Metrics Drive Appraisal Value at Scale?

Acquirers evaluate multi-location optometry groups through operational metrics that reveal efficiency, growth potential, and management capability. Understanding which metrics matter most helps operations leaders prioritize improvement efforts and document performance in ways that support higher valuations.

Patient Retention and Recall Rate Performance

Patient retention directly impacts valuation because it determines the predictability of future revenue. Multi-location groups that demonstrate strong recall rates across all locations show buyers that they have systems in place to maintain patient relationships, not just individual provider relationships.

Industry benchmarks suggest optometry practices should target recall rates that drive consistent patient return visits. Practices with documented recall systems and tracked performance data command premiums over those with inconsistent or undocumented patient retention. The key metric for multi-location groups is consistency of recall performance across locations, not just aggregate rates.

Buyers specifically examine whether high recall rates depend on individual staff members or systematic processes. A location with excellent recall driven by a single exceptional front desk employee presents risk that the rate will decline if that employee leaves. A location with similar rates driven by centralized recall campaigns and documented follow-up protocols demonstrates scalable systems that will persist post-acquisition. For groups looking to centralize patient recall across multiple locations, building this infrastructure before sale generates both operational and valuation benefits.

Revenue Per Exam and Capture Rate Analysis

Revenue per exam measures the productivity of each patient encounter, while capture rate measures conversion of exam patients into optical product sales. For multi-location groups, buyers examine both the absolute levels and the variance across locations.

According to industry benchmark data, optometry practices should target revenue per exam of $300 or higher, with capture rates of 60-70% as average and 75% or higher for top performers. Each percentage point improvement in capture rate can add $15,000-$30,000 in annual revenue per location, making this a high-impact optimization target.

The variance analysis matters as much as the averages. A group with consistent 65% capture rates across all locations presents differently than a group with rates ranging from 45% to 85%. High variance suggests operational inconsistency that buyers will need to address post-acquisition, potentially justifying valuation discounts. Low variance demonstrates standardized processes and training that buyers value.

Overhead Ratio and Labor Cost Benchmarks

Overhead ratios reveal operational efficiency and profit potential. According to Eyes on Eyecare’s 2024 industry report, healthy optometry practices maintain overhead between 55-65% of revenue. Groups exceeding 70% overhead face questions about operational efficiency that can reduce valuations.

Within the overhead category, labor costs typically represent the largest component at 22-25% of revenue for staffing. Multi-location groups can demonstrate operational maturity by showing consistent labor cost ratios across locations while maintaining service quality metrics. Groups that have optimized front desk staffing through centralized or hybrid models often show stronger overhead profiles than those with fully distributed staffing.

Buyers compare overhead ratios to their existing portfolio averages. Groups with higher-than-average overhead represent improvement opportunities that buyers will discount from the valuation but expect to capture post-acquisition. Groups with lower-than-average overhead demonstrate operational excellence that supports premium multiples.

Performance Variance as a Risk Indicator

Perhaps the most telling metric for multi-location groups is not any individual measure but rather the variance across locations. High variance in key metrics signals management challenges, inconsistent processes, or cultural issues that create integration risk for acquirers.

Operations leaders should calculate coefficient of variation for key metrics across their locations: revenue per exam, capture rate, recall rate, overhead ratio, and patient satisfaction scores. Groups with low variance demonstrate standardized operations that scale predictably. Groups with high variance will face questions about why locations perform so differently under common ownership.

Addressing variance often requires identifying root causes at underperforming locations and implementing standardized approaches that have succeeded elsewhere in the portfolio. This pre-sale operational standardization both improves valuation and reduces integration friction post-acquisition. For a comprehensive approach to operational cleanup before sale, variance reduction should be a primary focus.

How Does Centralized Patient Access Impact Your Group’s Valuation?

Centralized patient access, including centralized scheduling, call handling, and patient communication, has become a key differentiator in multi-location healthcare valuations. Groups that have already implemented centralized patient access demonstrate operational maturity that acquirers value, while also eliminating integration work the acquirer would otherwise need to complete.

The Centralization Premium in Acquisitions

PE-backed acquirers like AEG Vision, MyEyeDr, and Keplr Vision have invested heavily in centralized platforms that handle scheduling, billing, HR, and patient communications across their portfolios. When evaluating acquisition targets, these buyers specifically assess how easily a group can integrate into existing centralized systems.

Groups that have already centralized key functions present lower integration risk and faster time-to-value. The acquirer can connect the new locations to existing infrastructure rather than building new systems or managing parallel distributed operations during a transition period. This integration advantage translates to valuation premiums because the acquirer realizes synergy value faster.

The 2025 PE activity analysis from Vision Monday highlights that major acquirers specifically mention centralized platforms as a strategic advantage. AEG Vision references its “best-in-class common platform” as a key value driver, while Keplr Vision emphasizes centralized support enabling doctors to focus on patient care.

Call Answer Rates and Scheduling Efficiency

Patient access metrics directly impact revenue and patient satisfaction. Multi-location groups with centralized call handling typically achieve higher answer rates than groups with distributed front desk call handling at each location. This matters for valuation because missed calls represent missed revenue and patient attrition.

Industry data suggests that healthcare practices miss 20-30% of inbound calls when relying solely on location-based front desk staff to handle phones while managing in-person patients. Centralized call centers or hybrid human-AI intake models can achieve answer rates exceeding 95%, capturing revenue that would otherwise be lost.

For a five-location optometry group averaging 50 calls per day per location, improving answer rate from 70% to 95% captures an additional 37 patient opportunities daily. At average revenue per patient of $300+, this represents significant recoverable revenue that acquirers will model into their valuation analysis. Groups that can document these improvements through historical data make a compelling case for premium valuations.

Centralized Operations as Scalability Proof

Beyond immediate operational benefits, centralized patient access demonstrates that the group has solved scalability challenges that acquirers care about. Adding locations to a group with centralized systems requires incremental rather than proportional investment in infrastructure.

This scalability proof matters because acquirers are buying growth potential, not just current cash flow. A group that can demonstrate adding a new location with minimal incremental administrative overhead presents a more attractive acquisition than one where each location requires full staffing and independent systems.

Operations leaders preparing for appraisal should document their centralization journey: what functions are centralized, what efficiency gains resulted, and what capacity exists for additional locations. This documentation supports the valuation narrative and provides acquirers with evidence for their investment committee presentations. For groups considering centralized scheduling implementations, completing this work before sale often generates returns through both operational savings and valuation premiums.

What Due Diligence Challenges Multiply With Each Location?

Due diligence complexity increases non-linearly with location count. A ten-location group does not face ten times the due diligence scrutiny of a single practice; it faces significantly more because acquirers must verify consistency, identify outliers, and assess portfolio-level risks that do not exist in single-practice transactions.

Compliance Verification Across All Sites

HIPAA compliance, state optometry regulations, and payor credentialing must be verified at every location. A compliance gap at one location creates risk for the entire portfolio and can derail transactions or justify significant valuation adjustments.

Multi-location groups should implement standardized compliance programs with documented evidence of adherence at each site. According to compliance guidance from AccountableHQ, best practices include a 12-month HIPAA compliance cycle with rapid updates after acquisitions, system changes, or relocations. Site-specific addenda with standardized evidence collection provide the documentation acquirers need during due diligence.

The compliance burden for operations leaders is preparing comprehensive documentation before buyer engagement. Acquirers will request compliance evidence for all locations, and delays or gaps in providing this documentation slow transactions and raise red flags. Groups that can produce complete compliance packages within days of request demonstrate operational maturity that supports valuation.

Financial Reconciliation and Allocation Complexities

Multi-location financial statements present reconciliation challenges that single-practice statements do not. Shared costs may be allocated differently across locations, inter-company transactions may obscure true profitability, and owner compensation may flow through various entities in complex structures.

Due diligence teams will reconstruct financials at the location level to understand which locations drive profitability and which consume capital. They will challenge allocation methodologies and request supporting documentation for any inter-company pricing. Complex structures that made sense for tax or legal purposes become liabilities during due diligence if they cannot be clearly explained and documented.

Operations leaders should work with transaction advisors to prepare a clean financial package before going to market. This includes location-level P&Ls with documented allocation methodologies, elimination schedules for inter-company transactions, and clear explanations of owner compensation across all entities. Preparing this package proactively avoids delays during due diligence and demonstrates sophistication that buyers appreciate.

Provider and Staff Dependency Assessment

Acquirers assess provider and staff dependency at every location. A practice where one optometrist sees 80% of patients presents retention risk if that provider leaves post-acquisition. Similarly, locations dependent on individual staff members for key functions like recall or optical sales present operational risk.

Due diligence will examine provider productivity distribution, staff tenure, compensation benchmarks, and employment arrangements at each location. Non-compete agreements, retention incentives, and succession plans become focus areas. Groups with balanced provider workloads and documented processes that do not depend on specific individuals present lower risk profiles.

For multi-location groups, this assessment compounds because each location may have different dependency patterns. A group might have excellent diversification at four locations but critical dependency at one. That single location can affect the valuation of the entire portfolio if the risk is significant enough.

Technology and System Integration Assessment

Multi-location groups typically operate multiple technology systems: practice management software, EHR systems, optical inventory management, and patient communication platforms. Due diligence examines what systems each location uses, how they integrate, and what migration or consolidation the acquirer will need to complete.

Groups with standardized technology stacks across all locations simplify this assessment and reduce integration risk estimates. Groups with different systems at each location, perhaps due to acquisition history, face questions about data migration, training requirements, and operational disruption during consolidation.

Operations leaders should document their technology environment thoroughly: what systems are in use, what integration exists, what data standards apply, and what migration capabilities they have tested. Groups that have already consolidated to a single platform demonstrate operational maturity. Those still operating multiple systems should have documented migration plans that acquirers can evaluate for feasibility and cost.

How Do PE Buyers and Strategic Acquirers Evaluate Multi-Location Groups Differently?

Not all buyers evaluate optometry groups the same way. Understanding the different perspectives of PE buyers, strategic acquirers, and OD-to-OD transitions helps sellers position their groups appropriately and negotiate from informed positions.

Private Equity Platform Building Logic

PE firms acquiring optometry practices typically operate in one of two modes: platform building or add-on acquisitions. Platform deals create new portfolio companies that will serve as foundations for future acquisitions. Add-on deals expand existing portfolio companies by acquiring practices that integrate into established platforms.

Platform deals command the highest valuations because PE firms are buying both current cash flow and future platform value. They seek groups with strong management teams, scalable operations, and geographic positioning that enables further expansion. Platform candidates typically need 10+ locations, proven growth trajectories, and management depth that can absorb additional acquisitions.

Add-on acquisitions receive lower multiples because the platform value already exists in the acquirer’s portfolio. However, add-ons benefit from competitive bidding when multiple PE-backed platforms compete for the same geographic markets. Groups positioned as attractive add-ons to multiple platforms can generate competitive tension that improves valuations. Understanding PE-backed healthcare operations helps sellers anticipate buyer priorities.

Strategic Acquirer Integration Priorities

Strategic acquirers, including existing optometry groups, optical retail chains, and healthcare systems, evaluate acquisitions based on strategic fit rather than pure financial return. A strategic acquirer might pay a premium for a group that fills a geographic gap, adds a capability like medical optometry or myopia management, or brings a patient population they want to serve.

These strategic priorities create opportunities for sellers whose groups offer specific advantages to particular buyers. A group with strong dry eye or myopia management programs might receive premium interest from acquirers building specialty service lines. A group in an underserved geographic market might attract multiple strategic acquirers competing for market entry.

Operations leaders should identify which strategic buyers might value their specific attributes and position their groups accordingly. This might mean emphasizing different aspects of the practice to different buyer types or timing market entry to coincide with strategic buyer expansion plans.

OD-to-OD Transition Considerations

Transitions to other optometrists or optometry groups follow different valuation logic than PE or strategic acquisitions. Individual OD buyers typically value practices based on what they can afford to pay while maintaining acceptable income levels and servicing acquisition debt. This creates natural caps on what individual buyers can pay, regardless of practice quality.

However, OD buyers may value factors that PE buyers discount, such as practice culture, community relationships, or practice style compatibility. Sellers who prioritize these factors may accept lower valuations from OD buyers in exchange for better cultural fit or legacy preservation.

For multi-location groups, OD buyers are typically limited to groups where the total transaction size remains manageable for individual financing. Larger groups almost inevitably attract PE or strategic buyers simply because few individual ODs can access sufficient capital for 5+ location acquisitions. Understanding the full guide for selling optometry practices helps sellers match their exit goals with appropriate buyer types.

What Framework Should Operations Leaders Use to Prepare for Appraisal?

Preparing a multi-location optometry group for appraisal requires systematic work across operational, financial, and strategic dimensions. Operations leaders who follow a structured preparation framework achieve better outcomes than those who engage buyers without preparation.

The 12-Month Pre-Sale Operational Improvement Plan

Optimal preparation begins 12-18 months before planned buyer engagement. This timeline allows sufficient time to implement operational improvements, demonstrate sustained performance, and document results that support valuation claims.

The first phase focuses on operational standardization: implementing consistent protocols across all locations, reducing variance in key metrics, and documenting standard operating procedures. This work should address the highest-variance metrics first, as these represent the most significant improvement opportunities and the most obvious due diligence risks.

The second phase addresses financial optimization: normalizing financial statements, optimizing overhead ratios, and ensuring clean financial records at all locations. This includes resolving any inter-company complexities, documenting allocation methodologies, and preparing location-level financial packages that acquirers will request.

The third phase involves strategic positioning: identifying target buyers, understanding their priorities, and positioning the group to appeal to the most attractive acquirer segments. This might include geographic expansion to fill gaps, service line development to match buyer interests, or management team strengthening to support platform-level valuations.

Documenting Operational Excellence for Buyers

Acquirers make valuation decisions based on documented evidence, not verbal claims. Operations leaders should build comprehensive documentation packages that demonstrate operational excellence across all dimensions that buyers evaluate.

This documentation should include historical performance data showing trends in key metrics, standard operating procedures that demonstrate systematic approaches, training materials that show how performance is maintained, and compliance records that verify regulatory adherence. The goal is enabling acquirers to verify claims quickly and completely, reducing due diligence friction and supporting premium valuations.

For each key metric, documentation should show current performance, historical trends, benchmarks against industry standards, and the systems that produce consistent results. Groups that can demonstrate sustained above-benchmark performance with documented systems supporting that performance make compelling investment cases.

Building the Right Advisory Team

Multi-location healthcare transactions require specialized expertise that general business advisors may lack. Operations leaders should assemble advisory teams with relevant transaction experience, including healthcare-focused M&A advisors, healthcare-specialized accountants, and attorneys experienced in healthcare transactions.

The right advisors bring transaction experience that helps sellers avoid common mistakes, market knowledge that supports realistic valuation expectations, and buyer relationships that can generate competitive interest. They also provide credibility with sophisticated buyers who expect sellers to have professional representation.

For guidance on selecting the right optometry practice broker, evaluate candidates based on optometry-specific transaction experience, understanding of PE and strategic buyer perspectives, and track record with multi-location transactions specifically.

Timing Market Entry for Optimal Results

Market conditions significantly impact achievable valuations. The optometry acquisition market moves in cycles driven by PE capital availability, interest rates, and strategic buyer activity levels. Timing market entry to coincide with favorable conditions can improve outcomes.

According to Physician Growth Partners’ Q1 2025 analysis, eye care PE activity rebounded in 2024 after a slowdown, with projections for continued strong activity through 2025-2026. However, market conditions vary by geography and practice type, so local analysis matters more than national trends.

Operations leaders should monitor market conditions while preparing their groups for sale. Being ready to act when conditions are favorable provides optionality that improves outcomes. This means maintaining sale-readiness even while waiting for optimal timing, so the group can move quickly when conditions align.

For operations leaders preparing multi-location optometry groups for appraisal, these additional resources provide detailed guidance on specific aspects of the process:

Sources

  1. Physician Growth Partners. State of Eye Care Private Equity Q1 2025. Analysis of PE transaction volume and market trends.

  2. Vision Monday. Private Equity and Practice Transitions in 2025. Industry analysis of major acquirer activity and strategy.

  3. ODSONS Finance. Methods of Valuing an Optometry Private Practice. Comprehensive guide to valuation methodologies.

  4. Scott Leune. DSO Acquisition Valuation Framework. Analysis of EBITDA multiples and valuation factors for multi-location healthcare groups.

  5. Eyes on Eyecare. 2024 Optometrist Report. Industry benchmarks for operational performance and compensation.

  6. AccountableHQ. Dental DSO HIPAA Compliance Across Multiple Locations. Best practices for multi-location compliance programs.

  7. Books and Benchmarks. Optometry Benchmarks: Overhead and Profitability. Financial benchmarks for independent optometry practices.

  8. IRS. Business Valuation Guidelines. General guidance on financial analysis and valuation methods; it does not establish optometry-specific multiples.

Managing optometry practice appraisals across 3+ locations? Request an enterprise assessment for your group to identify operational improvements that support premium valuations.